Cargando…
Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy
Background and study aims: Current guidelines recommend using endoscopic ultrasound (EUS), carcinoembryonic antigen (CEA) testing and cytology to manage incidental pancreatic cystic neoplasms (PCN); however, studies suggest a strategy including integrated molecular pathology (IMP) of cyst fluid may...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
© Georg Thieme Verlag KG
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612224/ https://www.ncbi.nlm.nih.gov/pubmed/26528505 http://dx.doi.org/10.1055/s-0034-1392016 |